An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
about
Radium-223 IN metastatic hormone-sensitive high-grade prostate cancer: initial experience.A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with 223Radium-dichloride.Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases.Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases.EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.[Radium-223 dichloride in patients with castration-refractory prostate cancer].Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective.Metastatic castration-resistant prostate cancer and the challenge of a patient with chronic kidney disease in hemodialysis.Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidenceRadium and other alpha emitters in prostate cancerCan bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?
P2860
Q47146368-1AFAEC2C-BDAE-4180-8A2E-29DCB0B71EECQ47236071-6E91B0DD-FA6B-48CE-A8F6-1D75BC30C43FQ47557622-1485C019-3AAD-47FB-A16B-7182C7ED39EDQ48582999-B9BD2633-40C2-4CD2-9538-A7A0B073335AQ49874595-89CE3CF0-9757-4311-BDF9-73F02F63F684Q50096181-CFF6C5B5-8D60-4C0D-BA58-265054390CF5Q50512926-B730678B-FDBB-4955-9D79-E4EB598C6C24Q55020070-4AC41BB4-B17E-49D9-8631-F10779225A53Q55287057-7204DDB9-625A-4424-857A-4233A4CC7651Q57106628-F48B9FEC-1F51-4F85-B6A6-6D77CE8D39BFQ57112384-8B97C042-0AEC-4AFD-8D11-AEC231FA2C2DQ58759090-02988875-F971-4BAD-A8C1-D842EBD14EF1
P2860
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
An exploratory analysis of alk ...... ALSYMPCA trial with radium-223
@ast
An exploratory analysis of alk ...... ALSYMPCA trial with radium-223
@en
type
label
An exploratory analysis of alk ...... ALSYMPCA trial with radium-223
@ast
An exploratory analysis of alk ...... ALSYMPCA trial with radium-223
@en
prefLabel
An exploratory analysis of alk ...... ALSYMPCA trial with radium-223
@ast
An exploratory analysis of alk ...... ALSYMPCA trial with radium-223
@en
P2093
P2860
P356
P1433
P1476
An exploratory analysis of alk ...... ALSYMPCA trial with radium-223
@en
P2093
D Heinrich
J M O'Sullivan
N J Vogelzang
R E Coleman
P2860
P304
P356
10.1093/ANNONC/MDX044
P577
2017-05-01T00:00:00Z